Literature DB >> 26139999

Use of magnetic resonance elastography for assessing liver functional reserve: A clinical study.

Bin Li1, Jie Min1, Wei-Ren Liang1, Guang-Qiang Zhang1, Jian-Jun Wu1, Kai Jin1, Wei Huang1, Cai-Yu Ying1, Ming Chao1.   

Abstract

AIM: To investigate the value of magnetic resonance elastography (MRE) with regard to assessing liver functional reserve.
METHODS: Data from inpatients diagnosed with a liver tumor at an interventional radiology department from July 2013 to June 2014 were analyzed. A 3.0 Tesla magnetic resonance unit was used to scan 32 patients with confirmed diagnoses of hepatocellular carcinoma (HCC); an MRE sequence was added to the protocol, and the data were reconstructed and analyzed by two attending radiologists. Regions of interest were identified in different slices of the non-tumor liver parenchyma to measure average stiffness. In addition, the indocyanine green (ICG) test was performed no more than 1 wk before or after the magnetic resonance examination for all 32 patients; the ICG retention rate at 15 min (ICGR-15) and the ICG plasma clearance rate (ICG-K) were recorded. Correlational analyses were performed between the liver stiffness values and the ICGR-15 as well as between the liver stiffness values and the ICG-K.
RESULTS: Magnetic resonance imaging, including an MRE sequence and the ICG test, was performed successfully in all 32 enrolled patients. None of the patients developed complications. The mean ± SD of the elasticity values measured by the two attending radiologists were 4.7 ± 2.2 kPa and 4.7 ± 2.1 kPa, respectively. The average liver stiffness value of the non-tumor parenchyma measured using MRE in HCC patients was 4.7 ± 2.2 kPa. The average ICGR-15 was 0.089 ± 0.077, and the average ICG-K was 0.19 ± 0.07. We found that the liver stiffness value of the non-tumor parenchyma was significantly and positively related to the ICGR-15 (r = 0.746, P < 0.01) as well as significantly and negatively related to the ICG-K (r = -0.599, P < 0.01). The ICGR-15 was significantly and negatively related to the ICG-K (r = -0.852, P < 0.01).
CONCLUSION: MRE is accurate and non-invasive; furthermore, it can be used to effectively assess the liver functional reserve of HCC patients.

Entities:  

Keywords:  Hepatocellular carcinoma; Indocyanine green clearance test; Liver fibrosis; Liver functional reserve; Magnetic resonance elastography

Mesh:

Substances:

Year:  2015        PMID: 26139999      PMCID: PMC4481448          DOI: 10.3748/wjg.v21.i24.7522

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Hepatocellular carcinoma: present status and future prospects.

Authors:  Josep M Llovet; Michel Beaugrand
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 2.  Assessing liver function.

Authors:  Samir G Sakka
Journal:  Curr Opin Crit Care       Date:  2007-04       Impact factor: 3.687

3.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  H Lau; K Man; S T Fan; W C Yu; C M Lo; J Wong
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

4.  Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Katsuhiro Sano; Hironobu Sou; Ali Muhi; Tsuyota Koshiishi; Richard L Ehman; Tsutomu Araki
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

5.  Comparison of interobserver agreement of magnetic resonance elastography with histopathological staging of liver fibrosis.

Authors:  Jurgen H Runge; Anneloes E Bohte; Joanne Verheij; Valeska Terpstra; Aart J Nederveen; Karin M J van Nieuwkerk; Rob J de Knegt; Bert C Baak; Peter L M Jansen; Ralph Sinkus; Jaap Stoker
Journal:  Abdom Imaging       Date:  2014-04

6.  Prediction of indocyanine green retention rate at 15 minutes by correlated liver function parameters before hepatectomy.

Authors:  Atsushi Nanashima; Takafumi Abo; Syuuichi Tobinaga; Takashi Nonaka; Hidetoshi Fukuoka; Shigekazu Hidaka; Hiroaki Takeshita; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu; Takashi Kudo
Journal:  J Surg Res       Date:  2011-05-17       Impact factor: 2.192

7.  Repeatability of magnetic resonance elastography for quantification of hepatic stiffness.

Authors:  Catherine D G Hines; Thorsten A Bley; Mary J Lindstrom; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2010-03       Impact factor: 4.813

8.  Assessment of hepatic reserve for indication of hepatic resection: how I do it.

Authors:  Ronnie T Poon; Sheung Tat Fan
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

Review 9.  Physiological and biochemical basis of clinical liver function tests: a review.

Authors:  Lisette T Hoekstra; Wilmar de Graaf; Geert A A Nibourg; Michal Heger; Roelof J Bennink; Bruno Stieger; Thomas M van Gulik
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

10.  Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Hyun Sik Woo; Mi Hye Yu; Ijin Joo; Eun Sun Lee; Ji Young Sohn; Kyung Boon Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

View more
  3 in total

1.  Tomoelastography based on multifrequency MR elastography predicts liver function reserve in patients with hepatocellular carcinoma: a prospective study.

Authors:  Huimin Lin; Yihuan Wang; Jiahao Zhou; Yuchen Yang; Xinxin Xu; Di Ma; Yongjun Chen; Chunxue Yang; Ingolf Sack; Jing Guo; Ruokun Li; Fuhua Yan
Journal:  Insights Imaging       Date:  2022-06-03

2.  Evolving strategies for liver fibrosis staging: Non-invasive assessment.

Authors:  Cristina Stasi; Stefano Milani
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

3.  Assessment of liver injury using indocyanine green fluorescence imaging.

Authors:  Yan Chen; Ge Liu; Yulin Wu; Huiming Cai
Journal:  Ann Transl Med       Date:  2021-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.